// App-Quantinova.ai

: FINAL TWO-YEAR RESULTS FROM THE RANDOMIZED ONYX ONE TRIAL IN HIGH BLEEDING RISK PATIENTS TREATED WITH 1-MONTH DAPT

Researchers

Presenter

  • Stephan Windecker

Principal Investigators

  • Elvin Kedhi

  • Azeem Latib

  • David Kandzari

  • Ajay Kirtane

  • Roxana Mehran

  • Matthew Price

  • Alexandre Abizaid

  • Daniel Simon

  • Stephen Worthley

  • Azfar Zaman

  • Gwenn Wetzels

  • Te-Hsin Lung

  • Steven Marx

  • Ziad Ali

  • Gregg Stone

Medical Centers

  • Inselspital, Bern University Hospital, Bern, Switzerland

Locations

  • Switzerland

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

  • Cardiovascular (CVS)

  • Pulmonary/Respiratory Diseases

Disease

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • Clopidogrel bisulfate

  • Umirolimus

  • Aspirin

  • Albyl-E

Outcome

  • N/A

Study Design

  • Randomized

  • Non Inferiority

  • Multinational

  • Prospective

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved